Regulation of ocular angiogenesis by microRNAs
Regulation of ocular angiogenesis by microRNAs
批准号:
8589873
负责人:
Shusheng Wang
金额:
$35.77万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2016-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This project focuses on microRNA mechanisms on ocular angiogenesis. Angiogenesis plays a central role in eye development and also many major blinding retinal diseases, such as age related macular degeneration (AMD).The discovery of MicroRNAs as small endogenous RNAs regulating gene expression post-transcriptionally has revolutionized our understanding of genetic pathway networks, and ignited tremendous studies to explore microRNA therapeutics for numerous diseases. Our broad long-term goals are: (a) to understand the mechanisms of how specific microRNAs regulate ocular vascular development and (b) to decipher the roles of these microRNAs in vascular retinopathies. Our recent studies show that a specific microRNA, miR-126, is an endothelial cell specific microRNA regulating angiogenic pathways in response to vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF). We also have preliminary data that miR-126 is expressed specifically in the endothelium in the retina/choroid, and is required for sprouting retinal angiogenesis. Our organizing hypothesis for this proposal is that by regulating multiple angiogenic pathways miR-126 plays a critical regulatory role in ocular angiogenesis and in the pathogenesis of neovascular AMD. As a small molecule with multiple regulatory functions, miR-126 would be an attractive therapeutic target for blinding vascular retinopathies. Specific Aim I is to define the expression pattern and regulation mechanism of miR-126 in the retina/choroid. Specific Aim II is to identify the requirement and mechanism whereby miR-126 regulates retinal vascular development. Specific Aim III is to determine the mechanism by which miR-126 regulates neovascularization in a laser induced choroidal neovascularization model.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanistic study and therapeutic development for subretinal fibrosis
-
批准号:10749681
-
项目类别:
-
资助金额:$38.82万
-
财政年份:2023
-
负责人:Shusheng Wang
-
依托单位:
Role of long noncoding RNAs in human ocular angiogenesis
-
批准号:9330862
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2016
-
负责人:Shusheng Wang
-
依托单位:
Role of long noncoding RNAs in human ocular angiogenesis
-
批准号:9762935
-
项目类别:
-
资助金额:$37.63万
-
财政年份:2016
-
负责人:Shusheng Wang
-
依托单位:
Regulation of ocular angiogenesis by microRNAs
-
批准号:8531950
-
项目类别:
-
资助金额:$35.74万
-
财政年份:2011
-
负责人:Shusheng Wang
-
依托单位:
Regulation of ocular angiogenesis by microRNAs
-
批准号:8916739
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2011
-
负责人:Shusheng Wang
-
依托单位:
Regulation of Ocular Angiogenesis by microRNAs
-
批准号:10202608
-
项目类别:
-
资助金额:$36.86万
-
财政年份:2011
-
负责人:Shusheng Wang
-
依托单位:
Regulation of ocular angiogenesis by microRNAs
-
批准号:8725162
-
项目类别:
-
资助金额:$36.87万
-
财政年份:2011
-
负责人:Shusheng Wang
-
依托单位:
Regulation of ocular angiogenesis by microRNAs
-
批准号:8162601
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2011
-
负责人:Shusheng Wang
-
依托单位:
国内基金
海外基金
眼表菌群影响糖尿病患者干眼发生的人群流行病学研究
-
批准号:82371110
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:邹海东
-
依托单位:
趋化因子及其受体介导的血源性干/祖细胞及血管内皮细胞在新生血管性眼病中免疫病理机制及干预
-
批准号:30972712
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2009
-
负责人:陆培荣
-
依托单位:
趋化因子及其受体与新生血管性眼病的形成机制及干预研究
-
批准号:30771978
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2007
-
负责人:陆培荣
-
依托单位: